BACKGROUND: HIV-infected individuals transitioning from incarceration to the community are at risk for loss of viral suppression. We compared the effects of imPACT, a multidimensional intervention to promote care engagement after release, to standard care on sustaining viral suppression after community re-entry. METHODS: This trial randomized 405 HIV-infected inmates being released from prisons in Texas and North Carolina with HIV-1 RNA levels <400 copies/mL to imPACT versus standard care. The imPACT arm received motivational interviewing prerelease and postrelease, referral to care within 5 days of release, and a cellphone for medication text reminders. The standard care arm received routine discharge planning and a cellphone for study staff contact. The primary outcome was the difference between arms in week 24 postrelease viral suppression (HIV-1 RNA <50 copies/mL) using intention-to-treat analysis with multiple imputation of missing data. RESULTS: The proportion with 24-week HIV-1 RNA <50 copies/mL was 60% and 61% in the imPACT and standard care arms, respectively [odds ratio for suppression 0.95 (95% confidence interval: 0.59 to 1.53)]. By week 6 postrelease, 86% in the imPACT arm versus 75% in the standard care arm attended at least 1 nonemergency clinic visit (P = 0.02). At week 24, 62% in both arms reported not missing any antiretroviral doses in the past 30 days (P > 0.99). CONCLUSIONS: Higher rates of HIV suppression and medical care engagement than expected based on previous literature were observed among HIV-infected patients with suppressed viremia released from prison. Randomization to a comprehensive intervention to motivate and facilitate HIV care access after prison release did not prevent loss of viral suppression. A better understanding of the factors influencing prison releasees' linkage to community care, medication adherence, and maintenance of viral suppression is needed to inform policy and other strategic approaches to HIV prevention and treatment.
RCT Entities:
BACKGROUND:HIV-infected individuals transitioning from incarceration to the community are at risk for loss of viral suppression. We compared the effects of imPACT, a multidimensional intervention to promote care engagement after release, to standard care on sustaining viral suppression after community re-entry. METHODS: This trial randomized 405 HIV-infected inmates being released from prisons in Texas and North Carolina with HIV-1 RNA levels <400 copies/mL to imPACT versus standard care. The imPACT arm received motivational interviewing prerelease and postrelease, referral to care within 5 days of release, and a cellphone for medication text reminders. The standard care arm received routine discharge planning and a cellphone for study staff contact. The primary outcome was the difference between arms in week 24 postrelease viral suppression (HIV-1 RNA <50 copies/mL) using intention-to-treat analysis with multiple imputation of missing data. RESULTS: The proportion with 24-week HIV-1 RNA <50 copies/mL was 60% and 61% in the imPACT and standard care arms, respectively [odds ratio for suppression 0.95 (95% confidence interval: 0.59 to 1.53)]. By week 6 postrelease, 86% in the imPACT arm versus 75% in the standard care arm attended at least 1 nonemergency clinic visit (P = 0.02). At week 24, 62% in both arms reported not missing any antiretroviral doses in the past 30 days (P > 0.99). CONCLUSIONS: Higher rates of HIV suppression and medical care engagement than expected based on previous literature were observed among HIV-infectedpatients with suppressed viremia released from prison. Randomization to a comprehensive intervention to motivate and facilitate HIV care access after prison release did not prevent loss of viral suppression. A better understanding of the factors influencing prison releasees' linkage to community care, medication adherence, and maintenance of viral suppression is needed to inform policy and other strategic approaches to HIV prevention and treatment.
Authors: Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar Journal: AIDS Patient Care STDS Date: 2010-06 Impact factor: 5.078
Authors: David A Wohl; Anna Scheyett; Carol E Golin; Becky White; Jeanine Matuszewski; Michael Bowling; Paula Smith; Faye Duffin; David Rosen; Andrew Kaplan; JoAnne Earp Journal: AIDS Behav Date: 2011-02
Authors: Alexei Zelenev; Ruthanne Marcus; Artem Kopelev; Jacqueline Cruzado-Quinones; Anne Spaulding; Maureen Desabrais; Tom Lincoln; Frederick L Altice Journal: AIDS Behav Date: 2013-10
Authors: Carol E Golin; Jo Anne Earp; Catherine A Grodensky; Shilpa N Patel; Chirayath Suchindran; Megha Parikh; Seth Kalichman; Kristine Patterson; Heidi Swygard; E Byrd Quinlivan; Kemi Amola; Zulfiya Chariyeva; Jennifer Groves Journal: AIDS Behav Date: 2012-07
Authors: Roderick J Little; Ralph D'Agostino; Michael L Cohen; Kay Dickersin; Scott S Emerson; John T Farrar; Constantine Frangakis; Joseph W Hogan; Geert Molenberghs; Susan A Murphy; James D Neaton; Andrea Rotnitzky; Daniel Scharfstein; Weichung J Shih; Jay P Siegel; Hal Stern Journal: N Engl J Med Date: 2012-10-04 Impact factor: 91.245
Authors: Bethany L DiPrete; Brian W Pence; Carol E Golin; Kevin Knight; Patrick M Flynn; Jessica Carda-Auten; Jennifer S Groves; Kimberly A Powers; Becky L White; Sonia Napravnik; David A Wohl Journal: AIDS Behav Date: 2019-09
Authors: Lauren M Hill; Carol E Golin; Nisha C Gottfredson; Brian W Pence; Bethany DiPrete; Jessica Carda-Auten; Jennifer S Groves; Sonia Napravnik; David Wohl; Kevin Knight; Patrick M Flynn Journal: AIDS Behav Date: 2019-08
Authors: William E Cunningham; Robert E Weiss; Terry Nakazono; Mark A Malek; Steve J Shoptaw; Susan L Ettner; Nina T Harawa Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Divya K Chandra; Alexander R Bazazi; Muzammil A Nahaboo Solim; Adeeba Kamarulzaman; Frederick L Altice; Gabriel J Culbert Journal: HIV Res Clin Pract Date: 2019-05-01
Authors: Katerina A Christopoulos; William E Cunningham; Curt G Beckwith; Irene Kuo; Carol E Golin; Kevin Knight; Patrick M Flynn; Anne C Spaulding; Lara S Coffin; Bridget Kruszka; Ann Kurth; Jeremy D Young; Sharon Mannheimer; Heidi M Crane; Shoshana Y Kahana Journal: AIDS Behav Date: 2017-11
Authors: Katerina A Christopoulos; Elise D Riley; Adam W Carrico; Jacqueline Tulsky; Judith T Moskowitz; Samantha Dilworth; Lara S Coffin; Leslie Wilson; Jason Johnson Peretz; Joan F Hilton Journal: Clin Infect Dis Date: 2018-08-16 Impact factor: 9.079
Authors: Michael Costa; Brian T Montague; Liza Solomon; Cara Sammartino; Roee Gutman; Chava Zibman; David Rosen; Josiah D Rich Journal: J Urban Health Date: 2018-08 Impact factor: 3.671
Authors: Kelsey B Loeliger; Frederick L Altice; Mayur M Desai; Maria M Ciarleglio; Colleen Gallagher; Jaimie P Meyer Journal: Lancet HIV Date: 2017-11-27 Impact factor: 12.767